Cargando…

Functional Impact of the Ryanodine Receptor on the Skeletal Muscle L-Type Ca(2+) Channel

L-type Ca(2+) channel (L-channel) activity of the skeletal muscle dihydropyridine receptor is markedly enhanced by the skeletal muscle isoform of the ryanodine receptor (RyR1) (Nakai, J., R.T. Dirksen, H.T. Nguyen, I.N. Pessah, K.G. Beam, and P.D. Allen. 1996. Nature. 380:72–75.). However, the depen...

Descripción completa

Detalles Bibliográficos
Autores principales: Avila, Guillermo, Dirksen, Robert T.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233760/
https://www.ncbi.nlm.nih.gov/pubmed/10736313
_version_ 1782150293642805248
author Avila, Guillermo
Dirksen, Robert T.
author_facet Avila, Guillermo
Dirksen, Robert T.
author_sort Avila, Guillermo
collection PubMed
description L-type Ca(2+) channel (L-channel) activity of the skeletal muscle dihydropyridine receptor is markedly enhanced by the skeletal muscle isoform of the ryanodine receptor (RyR1) (Nakai, J., R.T. Dirksen, H.T. Nguyen, I.N. Pessah, K.G. Beam, and P.D. Allen. 1996. Nature. 380:72–75.). However, the dependence of the biophysical and pharmacological properties of skeletal L-current on RyR1 has yet to be fully elucidated. Thus, we have evaluated the influence of RyR1 on the properties of macroscopic L-currents and intracellular charge movements in cultured skeletal myotubes derived from normal and “RyR1-knockout” (dyspedic) mice. Compared with normal myotubes, dyspedic myotubes exhibited a 40% reduction in the amount of maximal immobilization-resistant charge movement (Q(max), 7.5 ± 0.8 and 4.5 ± 0.4 nC/μF for normal and dyspedic myotubes, respectively) and an approximately fivefold reduction in the ratio of maximal L-channel conductance to charge movement (G(max)/Q(max)). Thus, RyR1 enhances both the expression level and Ca(2+) conducting activity of the skeletal L-channel. For both normal and dyspedic myotubes, the sum of two exponentials was required to fit L-current activation and resulted in extraction of the amplitudes (A(fast) and A(slow)) and time constants (τ(slow) and τ(fast)) for each component of the macroscopic current. In spite of a >10-fold in difference current density, L-currents in normal and dyspedic myotubes exhibited similar relative contributions of fast and slow components (at +40 mV; A(fast)/[A(fast) + A(slow)] ∼ 0.25). However, both τ(fast) and τ(slow) were significantly (P < 0.02) faster for myotubes lacking the RyR1 protein (τ(fast), 8.5 ± 1.2 and 4.4 ± 0.5 ms; τ(slow), 79.5 ± 10.5 and 34.6 ± 3.7 ms at +40 mV for normal and dyspedic myotubes, respectively). In both normal and dyspedic myotubes, (−) Bay K 8644 (5 μM) caused a hyperpolarizing shift (∼10 mV) in the voltage dependence of channel activation and an 80% increase in peak L-current. However, the increase in peak L-current correlated with moderate increases in both A(slow) and A(fast) in normal myotubes, but a large increase in only A(fast) in dyspedic myotubes. Equimolar substitution of Ba(2+) for extracellular Ca(2+) increased both A(fast) and A(slow) in normal myotubes. The identical substitution in dyspedic myotubes failed to significantly alter the magnitude of either A(fast) or A(slow). These results demonstrate that RyR1 influences essential properties of skeletal L-channels (expression level, activation kinetics, modulation by dihydropyridine agonist, and divalent conductance) and supports the notion that RyR1 acts as an important allosteric modulator of the skeletal L-channel, analogous to that of a Ca(2+) channel accessory subunit.
format Text
id pubmed-2233760
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22337602008-04-22 Functional Impact of the Ryanodine Receptor on the Skeletal Muscle L-Type Ca(2+) Channel Avila, Guillermo Dirksen, Robert T. J Gen Physiol Original Article L-type Ca(2+) channel (L-channel) activity of the skeletal muscle dihydropyridine receptor is markedly enhanced by the skeletal muscle isoform of the ryanodine receptor (RyR1) (Nakai, J., R.T. Dirksen, H.T. Nguyen, I.N. Pessah, K.G. Beam, and P.D. Allen. 1996. Nature. 380:72–75.). However, the dependence of the biophysical and pharmacological properties of skeletal L-current on RyR1 has yet to be fully elucidated. Thus, we have evaluated the influence of RyR1 on the properties of macroscopic L-currents and intracellular charge movements in cultured skeletal myotubes derived from normal and “RyR1-knockout” (dyspedic) mice. Compared with normal myotubes, dyspedic myotubes exhibited a 40% reduction in the amount of maximal immobilization-resistant charge movement (Q(max), 7.5 ± 0.8 and 4.5 ± 0.4 nC/μF for normal and dyspedic myotubes, respectively) and an approximately fivefold reduction in the ratio of maximal L-channel conductance to charge movement (G(max)/Q(max)). Thus, RyR1 enhances both the expression level and Ca(2+) conducting activity of the skeletal L-channel. For both normal and dyspedic myotubes, the sum of two exponentials was required to fit L-current activation and resulted in extraction of the amplitudes (A(fast) and A(slow)) and time constants (τ(slow) and τ(fast)) for each component of the macroscopic current. In spite of a >10-fold in difference current density, L-currents in normal and dyspedic myotubes exhibited similar relative contributions of fast and slow components (at +40 mV; A(fast)/[A(fast) + A(slow)] ∼ 0.25). However, both τ(fast) and τ(slow) were significantly (P < 0.02) faster for myotubes lacking the RyR1 protein (τ(fast), 8.5 ± 1.2 and 4.4 ± 0.5 ms; τ(slow), 79.5 ± 10.5 and 34.6 ± 3.7 ms at +40 mV for normal and dyspedic myotubes, respectively). In both normal and dyspedic myotubes, (−) Bay K 8644 (5 μM) caused a hyperpolarizing shift (∼10 mV) in the voltage dependence of channel activation and an 80% increase in peak L-current. However, the increase in peak L-current correlated with moderate increases in both A(slow) and A(fast) in normal myotubes, but a large increase in only A(fast) in dyspedic myotubes. Equimolar substitution of Ba(2+) for extracellular Ca(2+) increased both A(fast) and A(slow) in normal myotubes. The identical substitution in dyspedic myotubes failed to significantly alter the magnitude of either A(fast) or A(slow). These results demonstrate that RyR1 influences essential properties of skeletal L-channels (expression level, activation kinetics, modulation by dihydropyridine agonist, and divalent conductance) and supports the notion that RyR1 acts as an important allosteric modulator of the skeletal L-channel, analogous to that of a Ca(2+) channel accessory subunit. The Rockefeller University Press 2000-04-01 /pmc/articles/PMC2233760/ /pubmed/10736313 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Original Article
Avila, Guillermo
Dirksen, Robert T.
Functional Impact of the Ryanodine Receptor on the Skeletal Muscle L-Type Ca(2+) Channel
title Functional Impact of the Ryanodine Receptor on the Skeletal Muscle L-Type Ca(2+) Channel
title_full Functional Impact of the Ryanodine Receptor on the Skeletal Muscle L-Type Ca(2+) Channel
title_fullStr Functional Impact of the Ryanodine Receptor on the Skeletal Muscle L-Type Ca(2+) Channel
title_full_unstemmed Functional Impact of the Ryanodine Receptor on the Skeletal Muscle L-Type Ca(2+) Channel
title_short Functional Impact of the Ryanodine Receptor on the Skeletal Muscle L-Type Ca(2+) Channel
title_sort functional impact of the ryanodine receptor on the skeletal muscle l-type ca(2+) channel
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233760/
https://www.ncbi.nlm.nih.gov/pubmed/10736313
work_keys_str_mv AT avilaguillermo functionalimpactoftheryanodinereceptorontheskeletalmuscleltypeca2channel
AT dirksenrobertt functionalimpactoftheryanodinereceptorontheskeletalmuscleltypeca2channel